Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
- PMID: 3951539
- DOI: 10.1038/319675a0
Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
Abstract
Metazoan organisms may discriminate between self and non-self not only by the presence of foreign antigens but also by the absence of normal self markers. Mammalian adaptive immune responses use the first strategy, with the additional requirement that foreign antigens are recognized in the context of self-major histocompatibility complex (MHC) products at the cell surface. Aberrant cells which fail to express MHC products adequately can therefore avoid detection. A more primitive but complementary defence system, eliminating such cells on the basis of absent self-markers, is suggested by a re-interpretation of phenomena associated with metastasis and natural resistance. We now show that murine lymphoma cells selected for loss of H-2 expression are less malignant after low-dose inoculation in syngeneic hosts than are wild-type cells, and that the rejection of such cells is non-adaptive. On the basis of our data, we suggest that natural killer cells are effector cells in a defence system geared to detect the deleted or reduced expression of self-MHC.
Similar articles
-
Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.J Immunol. 1988 Jan 15;140(2):671-8. J Immunol. 1988. PMID: 3335786
-
MHC gene control of the natural killer system at the level of the target and the host.Semin Cancer Biol. 1991 Oct;2(5):295-309. Semin Cancer Biol. 1991. PMID: 1773046 Review.
-
Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.Cancer Res. 1995 May 1;55(9):1911-6. Cancer Res. 1995. PMID: 7728758
-
Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.J Immunol. 1993 Jul 1;151(1):244-55. J Immunol. 1993. PMID: 8326126
-
Receptors that turn on and turn off natural killer cells.J Heart Lung Transplant. 1996 Jul;15(7):675-83. J Heart Lung Transplant. 1996. PMID: 8820783 Review.
Cited by
-
Gastroprotective effects of the nonsaponin fraction of Korean Red Ginseng through cyclooxygenase-1 upregulation.J Ginseng Res. 2020 Jul;44(4):655-663. doi: 10.1016/j.jgr.2019.11.001. Epub 2019 Nov 15. J Ginseng Res. 2020. PMID: 32617046 Free PMC article.
-
Natural killer cell therapies.Nature. 2024 Feb;626(8000):727-736. doi: 10.1038/s41586-023-06945-1. Epub 2024 Feb 21. Nature. 2024. PMID: 38383621 Review.
-
Behçet's Disease: Do Natural Killer Cells Play a Significant Role?Front Immunol. 2015 Mar 24;6:134. doi: 10.3389/fimmu.2015.00134. eCollection 2015. Front Immunol. 2015. PMID: 25852697 Free PMC article. Review.
-
CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells.Cancers (Basel). 2020 Sep 13;12(9):2612. doi: 10.3390/cancers12092612. Cancers (Basel). 2020. PMID: 32933182 Free PMC article.
-
Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.Am J Transplant. 2016 Nov;16(11):3121-3130. doi: 10.1111/ajt.13865. Epub 2016 Jul 7. Am J Transplant. 2016. PMID: 27163757 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
